Indications

Indications for immunotherapy in the treatment of allergic rhinitis based on the ARIA consensus and for the treatment of allergic asthma based on the WHO consensus

See rhinitis classification
See asthma classification

Contraindications

- Serious immune deficiency
- Malignant disease
- Treatment with beta-blockers, even those administered locally (drops)
- Severe asthma uncontrolled by drug treatment (FEV₁ <=70% of the predicted value, even after drug treatment)
- Non-compliant patient


Relative contraindications

- Children under 5 years of age
- During pregnancy